C. Peña, M.A. Dominguez, M. Pujol, R. Verdaguer, F. Gudiol, J. Ariza

Slides:

Advertisements

Similar presentations

Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages

Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Development of resistance in Pseudomonas aeruginosa obtained from patients with cystic fibrosis at different times F.B. Spencker, L. Staber, T. Lietz,

Characteristics of Clostridium difficile strains isolated from asymptomatic individuals and from diarrheal patients S. Wongwanich, P. Pongpech, C. Dhiraputra,

L. Pumbwe, D.W. Wareham, J. Aduse-Opoku, J.S. Brazier, H.M. Wexler

Frequency and molecular diversity of Pseudomonas aeruginosa upon admission and during hospitalization: a prospective epidemiologic study Dominique S.

Typing of Pseudomonas aeruginosa strains from patients with cystic fibrosis: phenotyping versus genotyping Nicole Renders, Alex van Belkum, Alfonso Barth,

An outbreak of hospital-acquired Pseudomonas aeruginosa infection caused by contaminated bottled water in intensive care units T. Eckmanns, M. Oppert,

Approach to diagnosis of infective endocarditis

Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β- lactamase-producing clone with a heterogeneous carbapenem resistance.

Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients

Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America

Herpes zoster in non-hospitalized children

Spread of colistin resistant non-mucoid Pseudomonas aeruginosa among chronically infected Danish cystic fibrosis patients Helle Krogh Johansen, Samuel.

C.-S. Lee, J.-H. Lee Clinical Microbiology and Infection

Integron-mediated antibiotic multiresistance in Acinetobacter baumannii clinical isolates from Spain J. Ruiz, M.M. Navia, C. Casals, J.M. Sierra, M.T.

R. Cantón Clinical Microbiology and Infection

Nosocomial spread of Pseudomonas aeruginosa producing the metallo-β-lactamase VIM-2 in a Spanish hospital: clinical and epidemiological implications

Neonatal listeriosis in Algeria: the first two cases

Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa E. Edalucci, R. Spinelli, L. Dolzani,

D.S. Hansen, R. Skov, J.V. Benedí, V. Sperling, H.J. Kolmos

How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development R. Bax Clinical Microbiology.

Epidemiologic characterization of Pseudomonas aeruginosa clinical isolates in a university hospital of southwestern Greece F.A. Paliogianni, M. Christofidou,

Pan-drug-resistant Pseudomonas aeruginosa causing nosocomial infection at a university hospital in Taiwan P.R. Hsueh, S.P. Tseng, L.J. Teng, S.W. Ho

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach D. Guillemot Clinical Microbiology.

Community-acquired methicillin-resistant Staphylococcus aureus infections: an emerging threat in Spain A. Manzur, A.M. Dominguez, M. Pujol, M.P.M. González,

PCR-based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed-field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem- and.

Vector control: a cornerstone in the malaria elimination campaign

Breast milk causing neonatal sepsis and death

C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins

S. Hosoglu, M. Loeb, M.F. Geyik, H. Ucmak, P. Jayaratne

Multicenter study of the in vitro activity of cefepime in comparison with five other broad- spectrum antibiotics against clinical isolates of Gram-positive.

Training for the infectious diseases speciality in Norway

D. Esel, B. Sümerkan, S. Kocagöz Clinical Microbiology and Infection

Laboratory diagnosis and biosafety issues of biological warfare agents

Computerized restriction endonuclease analysis compared with O-serotype and phage type in the epidemiologic fingerprinting of Pseudomonas aeruginosa strains

Phenotypic and genotypic characterization of Neisseria gonorrhoeae in parts of Italy: detection of a multiresistant cluster circulating in a heterosexual.

In vitro selection of antibiotic resistance in Pseudomonas aeruginosa

Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-β- lactamase-producing clone with a heterogeneous carbapenem resistance.

C. Silva-Costa, F.R. Pinto, M. Ramirez, J. Melo-Cristino

Anders Österlund, Lars Engstrand Clinical Microbiology and Infection

Characterisation of non-multiresistant methicillin-resistant Staphylococcus aureus (including EMRSA-15) in Kuwait Hospitals E.E. Udo, N. Al-Sweih, B.

Laboratory diagnosis of Clostridium difficile disease

Klebsiella pneumoniae: development of a mixed population of carbapenem and tigecycline resistance during antimicrobial therapy in a kidney transplant.

Pathogenesis of catheter-related infections: lessons for new designs

Outbreak of infection with high-level gentamicin-resistant Enterococcus faecalis (HLGRE) in a Norwegian hospital Ø. Wendelbo, R. Jureen, G.E. Eide, A.

Y. Tveten, A. Jenkins, A.G. Allum, B.-E. Kristiansen

Methicillin-susceptible Staphylococcus aureus clone related to the early pandemic phage type 80/81 causing an outbreak among residents of three occupational.

Fibronectin concentrations in catheter sepsis

Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium Stig Harthug, A. Digranes, O. Hope, B.E. Kristiansen,

Statin use and clinical outcomes among pneumonia patients

Clinical Microbiology and Infection

Infrequent detection of acquired metallo-β-lactamases among carbapenem-resistant Pseudomonas isolates in a Greek hospital A. Tsakris, P.T. Tassios, F.

Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe Robert D. Fox Clinical Microbiology.

Abstracts Clinical Microbiology and Infection

A. Manzur, F. Gudiol Clinical Microbiology and Infection

P. Mastrantonio, P. Stefanelli, F. Conti, R. Cardines, T. Sofia, S

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group† H. Goossens Clinical.

J.L. Balcázar Clinical Microbiology and Infection

G.C. Schito Clinical Microbiology and Infection

F. B. Spencker, S. Haupt, M. C. Claros, S. Walter, T. Lietz, R

Typing of Clostridium difficile

J.A. Pérez-Molina, F. Fernández Clinical Microbiology and Infection

Impact of antibiotic restrictions: the patient's perspective

A family outbreak due to an emm-type 11 multiresistant strain of Streptococcus pyogenes C. Martinaud, A. Doloy, B. Graffin, T. Gaillard, R. Poyet, S.

B. Martha, D. Croisier, A. Fanton, K. Astruc, L. Piroth, F. Huet, P

Combination of pulsed-field gel electrophoresis (PFGE) and single-enzyme amplified fragment length polymorphism (SAFLP) for differentiation of multiresistant.

The future of diagnostic bacteriology

Presentation transcript:

An outbreak of carbapenem-resistant Pseudomonas aeruginosa in a urology ward C. Peña, M.A. Dominguez, M. Pujol, R. Verdaguer, F. Gudiol, J. Ariza Clinical Microbiology and Infection Volume 9, Issue 9, Pages 938-943 (September 2003) DOI: 10.1046/j.1469-0691.2003.00686.x Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Number of patients colonized or infected with carbapenem-resistant P. aeruginosa over the course of the outbreak. Clinical Microbiology and Infection 2003 9, 938-943DOI: (10.1046/j.1469-0691.2003.00686.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 PFGE of six carbapenem-resistant P. aeruginosa isolates following SpeI restriction. Lanes 1–2, isolates from unrelated patients; lanes 3–6, dominant carbapenem-resistant P. aeruginosa clone from samples from urology patients. M, molecular weight markers (low range PFG marker, New England Biolabs Inc., Beverly, MA, USA). Clinical Microbiology and Infection 2003 9, 938-943DOI: (10.1046/j.1469-0691.2003.00686.x) Copyright © 2003 European Society of Clinical Infectious Diseases Terms and Conditions